Sonoma Pharmaceuticals has established strategic partnerships around the globe with leaders in the dermatology, advanced wound care and animal healthcare markets
Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care. The company’s products, which are sold throughout the United States and internationally, have improved outcomes for more than five million patients globally by reducing infections, itch, pain, scarring and harmful inflammatory responses. The company’s headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America. European marketing and sales are headquartered in Roermond, Netherlands.
Our partners in the Chinese marketplace, Tianjin Ascent Technology Co., Ltd. and Shanghai Sunvic Technology Development Co., Ltd., are leading distributors of the Microcyn®-based products, distributing Sonoma’s products to both medical professionals and consumers.
Sonoma’s premiere partner in India, Genetix, is an innovative leader in the Indian life sciences market and offers a dominant distribution network of branch offices and over 30 distributors throughout India.
Sonoma’s partner, Sanfer is the leading Mexican private market pharmaceutical company with sales throughout Latin America and the Caribbean and over 80 years of experience in the pharmaceutical industry. Sanfer’s business model is primarily focused on the development, manufacturing and commercialization of patented and off-patent branded specialty pharmaceuticals products.
- Gramaderm® Solution
- Gramaderm® Hydrogel
Sonoma’s partner in the Middle East is MicroSafe Care International, based out of Dubai and the United Arab Emirates. MicroSafe develops and markets Microcyn®-based products in the United Arab Emirates, Kingdom of Saudi Arabia, Bahrain, Kuwait and Iraq.
- Dermacyn Wound Care Solution
- Microcyn Wound & Burn Hydrogel
- Epicyn Scar Hydrogel
- Pediacyn Atopic/Radiation Dermatitis
Sonoma’s partner in Singapore and Malaysia, Dyamed Biotech, was established in 1998 to distribute quality medical products in Southeast Asia. The company distributes primarily to hospitals and has an established network of contacts in both public and private hospitals. Besides hospitals, Dyamed Biotech also distributes to clinics and pharmacies in Singapore and Malaysia. The company’s vision is to provide a growing and valuable range of innovative medical products, coupled with a high level of customer service.
- Dermacyn Advanced Wound Care Products
- EZyma hydrogel
- ScarLess hydrogel
Sonoma’s partner in Australia and New Zealand, Te Arai BioFarma Limited, is a privately owned company specializing in vaccines, as well as biological and specialty medicines that aim to improve health and productivity through the affordable control and prevention of disease.
Since 2000 C&C Health Care Co. Ltd. located in Seoul, South Korea has been striving to improve the people`s welfare, health, and quality of life by providing superior wound, scar, and acne products from Sonoma pharmaceuticals Inc.
Company name: C&C Health Care Co., Ltd.
Address: #1903-1904, B-dong, Woolimblue nine Business center, 583 Yangcheon-ro, Gangseo-gu, S.Korea
Contact info: Tel : +82 2-334-2011 Fax : +82 2-334-1788
E-mail address: firstname.lastname@example.org